Log In
BCIQ
Print this Print this
 

stiripentol (Diacomit) (ME2080)

  Manage Alerts
Collapse Summary General Information
Company Laboratoires Biocodex
DescriptionAnticonvulsant
Molecular Target Cytochrome P450 (p450)
Mechanism of ActionCytochrome P450 inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEpilepsy
Indication DetailsTreat refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy; Treat severe myoclonic epilepsy in infants
Regulatory Designation Japan - Orphan Drug (Treat refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy)
PartnerMeiji Seika Pharma Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today